AI assistant
USCOM LIMITED — Investor Presentation 2015
Sep 3, 2015
65979_rns_2015-09-03_f180f8c7-c348-434d-83ef-855ffde9ae3d.pdf
Investor Presentation
Open in viewerOpens in your device viewer
Proactive Investors
September 2015
Uscom (UCM) – Medical Devices and Revenue Growth
==> picture [842 x 118] intentionally omitted <==
Rob Phillips
PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Executive Chairman/CEO
The Measure of Life
Disclaimer
This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter. The information in this presentation, whether written or verbal, has been prepared without taking into account the commercial, financial or other needs of any individual or organisation.
While Uscom (the "Company”) has taken due care in compiling the information, neither the Company nor its officers or advisors or any other person warrants the accuracy, reliability, completeness or timeliness of the information or guarantees the commercial or investment performance of the Company. Certain information may relate to protected intellectual property rights owned by Uscom. By viewing this presentation the viewer accepts the terms of the accompanying Company NDA. The information does not constitute advice of any kind and should not be relied on as such. Investors must make their own independent assessment of the Company and undertake such additional enquiries as they deem necessary or appropriate for their own investment purposes. Any and all use of the information is at your own risk.
Uscom
Products generate profit
High growth (+50% pa), innovative medical device company Outstanding science Key cardiovascular pulmonary markets and multiple products De-risked technology Poised for strategic growth with recent acquisitions Valuable IP with high margins (75+%) Unrecognised value - $15m market cap US growth from new products and reimbursement Fundamentals to drive value
4
==> picture [741 x 417] intentionally omitted <==
Uscom vision
Company of the Year, 2014 Johnson & Johnson Innovation Industry Excellence Awards
“A milestone driven global medical device company with real products, real revenue, real growth and an aggressive growth strategy”
==> picture [397 x 51] intentionally omitted <==
==> picture [219 x 97] intentionally omitted <==
Current Business
-
Premium noninvasive cardiovascular and pulmonary monitoring devices
-
Addressing the growing threat of superbugs, heart failure, hypertension and asthma
-
Validated, clinically accepted, cost and life saving devices with critical applications
-
IP protected with regulatory approvals
-
Uscom BP+ for market 2016 - $7m over 5years Chinese contract in place
-
+50% revenue growth in Asia and Europe, with US market ahead
Financials
-
Corporate Board & Management Financials
-
� ASX listed (UCM) � Rob Phillips, Chairman & CEO � Sales +59% 2015 � Headquartered in Sydney � Sheena Jack, Director � Revenue +48% 2015 � (HCF, Moneytime Health) ($2+m) Market cap of $15m
-
� 92m shares on issue � Christian Bernecker, Director � Cash consumption - <$1m � Rob Phillips, Founder and (Stream) � Gross Margins ~ 78% � Nick Schicht, General Manager �
-
CEO, holds 20% of Cash ~ $2m company
-
Uscom Annual report
New Acquisition
==> picture [220 x 92] intentionally omitted <==
==> picture [222 x 138] intentionally omitted <==
Uscom has acquired 100% of Thor Laboratories - Asthma
*
Company Overview
Uscom benefits
-
High fidelity digital Doppler spirometry devices
-
Cash flow positive, revenue of $500k
-
Established manufacturing - 15 years
-
Accredited international manufacturing
-
Global reach
-
4 + 3 products, CE, FDA, TGA approvals
-
Reimbursement in multiple markets
-
Global distribution
-
Strong R&D and grant history
-
Technical R&D team 16 engineers
-
Partners in Home Care Asthma in the USA
-
Marketing and management
Synergy of science, operations and strategy
- Agreement subject to DD and Uscom capital raise
Aus competitor $75m
New Products - Asthma
==> picture [77 x 102] intentionally omitted <==
Products in Market
New Products
Digital Doppler Spirometer
New – AsthmaHero
Drug delivery measure Telemetry to iPhone app Smart spacer Patient interactive
Home use
==> picture [155 x 141] intentionally omitted <==
==> picture [139 x 89] intentionally omitted <==
With Diagnostics and WIFI Digital wifi spirometer
==> picture [138 x 108] intentionally omitted <==
New - BreatheSmart
Digital wifi spirometer Remote clinical monitoring Cloud diagnosis
Professional System
Desktop with advanced software analytics
New - Whistler Neonatal Asthma diagnostic
Strategic growth
Complementary products and technology
Fluid, Sepsis & Heart Failure
-
US 1.3bn market[*]
-
CAGR of 7.6%[*]
-
CE, FDA, TGA, CFDA
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
Hypertension & Vascular Health
COPD
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
& Asthma
-
US 1.7bn market[*]
-
US 400m market[*]
-
CAGR of 11.5%[*]
-
CAGR of 6.5%[*]
-
CE, FDA, TGA
-
CE, TGA, FDA
USCOM 1A
Cardiac Output Monitoring
==> picture [190 x 195] intentionally omitted <==
Thor Pulmonary Monitoring
BP+
Blood Pressure Monitoring
==> picture [132 x 135] intentionally omitted <==
==> picture [175 x 107] intentionally omitted <==
Acquired July 2013 Aus competitor - $50m
Acquired Sept 2015 Aus competitor - $75m
- Source: MedTech Insight; Transparency Market Research
De-Risked technology
Featured in 400+ peer reviewed publications and presentations
==> picture [98 x 117] intentionally omitted <==
==> picture [102 x 125] intentionally omitted <==
==> picture [96 x 113] intentionally omitted <==
==> picture [94 x 110] intentionally omitted <==
==> picture [93 x 111] intentionally omitted <==
==> picture [93 x 112] intentionally omitted <==
==> picture [81 x 107] intentionally omitted <==
Sepsis, Heart failure, Hypertension, Fluid management, Emergency, Pediatrics, Cardiac transplantation, Electrophysiology, Emergency transport, Anesthesia, Liver transplantation, ICU, Pre-eclampsia, Pulmonary hypertension, Nurse outreach, Organ procurement, Haemodialysis, Neonates, infants, Children etc……..
Uscom People - Global
Nick Schicht Steve Haken Andrew Kenig
==> picture [103 x 126] intentionally omitted <==
==> picture [100 x 126] intentionally omitted <==
==> picture [111 x 125] intentionally omitted <==
Denise Pater Tina Wu Rik Denicke
==> picture [93 x 64] intentionally omitted <==
==> picture [85 x 127] intentionally omitted <==
==> picture [104 x 125] intentionally omitted <==
==> picture [93 x 64] intentionally omitted <==
Rob Phillips
==> picture [105 x 128] intentionally omitted <==
Global Euro Aus
Global Global USA Global
Bev Jacobson Richard Scott George Tang Lindy Belleza George Ferenczi Hagay Gilad Steve Wilson
==> picture [102 x 125] intentionally omitted <==
==> picture [107 x 124] intentionally omitted <==
==> picture [94 x 126] intentionally omitted <==
Global Global Aus
==> picture [97 x 124] intentionally omitted <==
Aus
==> picture [99 x 125] intentionally omitted <==
==> picture [93 x 125] intentionally omitted <==
Global Aus
==> picture [103 x 126] intentionally omitted <==
==> picture [36 x 13] intentionally omitted <==
----- Start of picture text -----
USA
----- End of picture text -----
Current growth
Revenue and Income
==> picture [348 x 273] intentionally omitted <==
----- Start of picture text -----
$2,500,000
$2,039,426
$2,000,000
$1,500,000 $1,377,716
$1,010,942
$1,000,000
$500,000
$0
2013 2014 2015
----- End of picture text -----
Distribution Agreements
==> picture [342 x 254] intentionally omitted <==
----- Start of picture text -----
40 38
35
30
27
25
20
15
12
10
5
0
2013 2014 2015
----- End of picture text -----
Distribution – sales – revenue Thor acquisition adds distribution and revenue
- FY to date
Operations growth
- Uscom Limited
Maintaining growth
-
Uscom UK
-
Uscom Budapest 4. Uscom Inc US
2 •[•] • •[• •] • •• 3
[• ] • • • • •[•] •
[•] • •
[•] •
4 •• • •• • • • • • • • • •
[•] • 1 US Focus 2016 Stephen Wilson – Former VP Corporate Development Welch Allyn appointed
Key Markets 1. AsiaPAC – 65% 2/3. Europe – 27% 4. Nth America – 8%
Revenue Targets
==> picture [653 x 397] intentionally omitted <==
----- Start of picture text -----
Thor
Total Revenue
20,000,000
18,000,000
16,000,000 BP+
14,000,000
12,000,000
Thor
$ 10,000,000
BP+
USCOM
8,000,000
USCOM
6,000,000
4,000,000
2,000,000
0
2015 2016 2017 2018 2019 2020
----- End of picture text -----*
==> picture [395 x 21] intentionally omitted <==
----- Start of picture text -----
$20m revenue by 2020 - 5 year CAGR of 58%
----- End of picture text -----
The Future
Value Cascade
==> picture [624 x 33] intentionally omitted <==
Products Sales Operations Opportunities USCOM 1A Current distribution Global operations Dividend Uscom BP+ Thor distribution Increased products Share price growth Spirotube New distribution Increased scale Transaction Otthon Completion of Major partners Cost effective CaS pi roDesktal Raise manufacture Re-imbursement BreatheSmart Revenue growth US market focus AsthmaHero Profitability ThorSoft
Products – Sales – Revenue - Opportunities
Business Risks & Mitigants
==> picture [733 x 392] intentionally omitted <==
----- Start of picture text -----
Risks Mitigants
� �
Global markets unpredictable Diversified and expanded products
� �
Competitiveness of market sectors Senior sales and marketing personnel
� �
Thor integration & key staff retention Earn outs in Thor deal structure
� �
Ongoing Thor business management Earn outs in Thor deal structure
� �
Thor distraction from USCOM & BP+ Product diversification
� �
Regulatory costs and timelines Additional focused resources
� �
Distribution & revenue growth Key Uscom and Thor staff
� �
Working capital requirements to Additional WC from capital raise
meet increased product demand
----- End of picture text -----
UCM Investment
==> picture [452 x 291] intentionally omitted <==
----- Start of picture text -----
ASX 10yr CAGR
14
12
10
8
% 6
4
2
0
Mining Financials Health BHP NAB Resmed
-2
----- End of picture text -----
UCM sales growth 2014 – 67% 2015 – 59%
Health outperforms!
*Dividend exclusive
*25[th] August
Market anomaly - opportunity
Opposing forces! Disconnect between performance and price
UCM share price
UCM Revenue and Income
==> picture [351 x 235] intentionally omitted <==
----- Start of picture text -----
$4,000,000
$3,500,000
$3,500,000
$3,000,000
$2,500,000
$2,039,426
$2,000,000
$1,377,716
$1,500,000
$1,010,942
$1,000,000
$500,000
$0
2013 2014 2015 2016
----- End of picture text -----*
Unrecognised value
- Estimate
Uscom
Value investment ✓ Strong growth phase ✓ ✓ Positioned for on going growth Strong underlying business ✓ Premium global markets ✓ Diversified and lifesaving technologies ✓ Sector leading management ✓ Aggressive global growth strategy ✓ Right time ✓
Proactive Investors
September 2015
Uscom (UCM) – Medical Devices and Revenue Growth
==> picture [842 x 118] intentionally omitted <==
Thanks
Rob Phillips
PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Executive Chairman/CEO